Ambry Genetics announced data identifying potential new genetic links to neurodevelopmental conditions.

Ambry Genetics announced data identifying potential new genetic links to neurodevelopmental conditions.
According to the news:

The findings, shared today in oral platform presentations at the American College of Medical Genetics and Genomics (ACMG) 2016 Annual Clinical Genetics Meeting in Tampa, FL, were based on genetic testing results conducted by Ambry, including diagnostic exome sequencing (DES).

Aaron Elliott, Ph.D., Chief Operating Officer and Interim Chief Scientific Officer, Ambry Genetics commented:

Neurodevelopmental disorders represent a challenging diagnosis because the underlying cause is not always readily understood. With exome sequencing and other genetic tests, we are starting to uncover disease-causing gene mutations in neurology that may have important clinical implications. The findings presented today in these oral presentations further add to our growing body of data that we hope will offer healthcare providers and their patients with some of the answers they are seeking.

Click here to view the full press release.